As Thailand transitions from the rainy to early winter seasons, respiratory infections surge dramatically, making awareness ...

Another preventive measure is monoclonal antibodies — artificially created proteins that can be given to infants to assist ...

It is a mistake to claim that there is not widespread research into the effectiveness of vaccines, especially those given to ...

Research shows RSV leads to high hospitalization rates in adults, emphasizing the importance of enhanced surveillance and ...

A medical panel appointed by Health Secretary Robert F. Kennedy Jr. voted Thursday to recommend a new monoclonal antibody ...

Respiratory syncytial virus (RSV) is a leading cause of acute lower respiratory infections (ALRTIs) in children under five and poses a persistent ...

Transmission has increased for RSV, Sundareshan said, and young children and adults older than 75 years are at the greatest risk of severe complications.

Vascimini A, Deravi M, Perez G, et al. Respiratory syncytial virus (RSV): Independent community pharmacy impact in promoting prevention through immunization. J Pharm Technol. Published online ...

Each year, approximately 177,000 adults aged 65 and older are hospitalized in the United States due to RSV, with an estimated 10,000 cases resulting in death. 4 In the Philippines, surveillance ...

What to know about RSV transmission and symptoms RSV is transmitted through large droplets of airborne fluid passed by coughing or sneezing.

Although a chest X-ray alone cannot confirm or rule out RSV, doctors will evaluate any complications, review the patient’s medical history, check oxygen levels, and perform a swab test for ...

Respiratory syncytial virus (RSV) vaccination in adults aged 60 years and older may be cost-effective in preventing illness, hospitalizations, lost quality of life, and deaths, according to one study.